1. Improved patient selection for primary prevention ICD implantation by predicting ICD non-benefit using artificial intelligence
- Author
-
M Z H Kolk, S Ruiperez-Campillo, B Deb, E J Bekkers, B D De Vos, A C J Van Der Lingen, C P Allaart, I Isgum, A J Rogers, P Clopton, A A M Wilde, R E Knops, S M Narayan, and F V Y Tjong
- Subjects
Physiology (medical) ,Cardiology and Cardiovascular Medicine - Abstract
Funding Acknowledgements Type of funding sources: Public grant(s) – National budget only. Main funding source(s): NWO Rubicon (452019308) Amsterdam Cardiovascular Sciences Background Left Ventricular Ejection Fraction (LVEF) is suboptimal as a sole marker for predicting sudden cardiac death (SCD) or benefit from an ICD. Machine (ML) and deep (DL) learning provide new opportunities for personalised predictions using complex, multi-modal physiological data. Objective We hypothesise that risk stratification for ICD implantation can be improved by ML and DL models that combine clinical variables with time series features from 12-lead electrocardiograms (ECG). Methods We present a multicentre study of 1010 patients with an ischaemic, dilated or non-ischaemic cardiomyopathy and LVEF≤35% implanted with an ICD between 2007 and 2021 for primary prevention of SCD (64.9 ±10.8 years, 73.2% male) in two academic hospitals. For each patient, raw 12-lead, 10-second ECG-recordings obtained Results At 3-year follow-up, 16.0% of patients had died of whom 72.8% met the criteria for ICD non-benefit. Extreme gradient boosting models identified subjects with ICD non-benefit with an area under the receiver operator curve (AUROC) of 0.897 ±0.05 during internal validation (Figure 1, solid line). In the external cohort, the AUROC was 0.793 (95% CI 0.75-0.84) (Figure 1, dashed line). Survival analysis for low vs. high predicted risk indicated ICD non-benefit rates of 6.0% versus 30.3% at 3-year follow-up, respectively (Figure 2). Conclusion A ML model that combined clinical with ECG features better predicted ICD non-benefit at 3-years in a primary prevention population than currently available risk scores such as the MADIT-ICD score. This approach may provide new tools to support personalized decision making for ICD therapy. Prospective validation is needed to assess the real-world clinical performance of the model.
- Published
- 2023
- Full Text
- View/download PDF